Slides: The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
Slides (presentation) - Apr. 15, 2019 - Melbourne, Australia - Prof. David Cherney, MD University of Toronto Toronto, Canada - PACE-CME symposium held during ISN-WCN 2019Slides as educational service to PACE members and meeting participants
This lecture was part of a CME-accredited symposium SGLT2 inhibition in CKD: Discussing the key questions and evidence held during ISN-WCN 2019 in Melbourne, Australia.
The presentation was prepared and held by dr. David Cherney, associate Professor in the Department of Medicine, University of Toronto and a Clinician Scientist at the University Health Network and
Mount Sinai Hospitals and director of the Renal Physiology Laboratory, Toronto, Canada
Disclosures
This CME symposium was supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly.
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: